Annual Total Long Term Liabilities
$1.11 B
+$69.90 M+6.73%
31 December 2023
Summary:
Cytokinetics Incorporated annual total long term liabilities is currently $1.11 billion, with the most recent change of +$69.90 million (+6.73%) on 31 December 2023. During the last 3 years, it has risen by +$718.74 million (+184.66%). CYTK annual total long term liabilities is now at all-time high.CYTK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$1.34 B
+$27.70 M+2.11%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly total long term liabilities is currently $1.34 billion, with the most recent change of +$27.70 million (+2.11%) on 30 September 2024. Over the past year, it has increased by +$238.47 million (+21.65%). CYTK quarterly long term liabilities is now at all-time high.CYTK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.7% | +21.6% |
| 3 y3 years | +184.7% | +169.3% |
| 5 y5 years | +579.5% | +621.5% |
CYTK Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +184.7% | at high | +169.3% |
| 5 y | 5 years | at high | +579.5% | at high | +621.5% |
| alltime | all time | at high | >+9999.0% | at high |
Cytokinetics Incorporated Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.34 B(+2.1%) |
| June 2024 | - | $1.31 B(+17.7%) |
| Mar 2024 | - | $1.12 B(+0.7%) |
| Dec 2023 | $1.11 B(+6.7%) | $1.11 B(+0.6%) |
| Sept 2023 | - | $1.10 B(+5.2%) |
| June 2023 | - | $1.05 B(+0.4%) |
| Mar 2023 | - | $1.04 B(+0.5%) |
| Dec 2022 | $1.04 B(+97.5%) | $1.04 B(+2.2%) |
| Sept 2022 | - | $1.02 B(+71.1%) |
| June 2022 | - | $593.46 M(-11.8%) |
| Mar 2022 | - | $673.14 M(+28.1%) |
| Dec 2021 | $525.60 M(+35.0%) | $525.60 M(+5.6%) |
| Sept 2021 | - | $497.65 M(+2.4%) |
| June 2021 | - | $486.05 M(+2.7%) |
| Mar 2021 | - | $473.29 M(+21.6%) |
| Dec 2020 | $389.22 M(+41.7%) | $389.22 M(+31.1%) |
| Sept 2020 | - | $296.93 M(+3.1%) |
| June 2020 | - | $287.88 M(+2.2%) |
| Mar 2020 | - | $281.55 M(+2.5%) |
| Dec 2019 | $274.73 M(+68.5%) | $274.73 M(+47.9%) |
| Sept 2019 | - | $185.75 M(+2.5%) |
| June 2019 | - | $181.16 M(+7.2%) |
| Mar 2019 | - | $168.96 M(+3.6%) |
| Dec 2018 | $163.05 M(+6.9%) | $163.05 M(+4.0%) |
| Sept 2018 | - | $156.72 M(+8.2%) |
| June 2018 | - | $144.78 M(+2.1%) |
| Mar 2018 | - | $141.78 M(-7.0%) |
| Dec 2017 | $152.52 M(+258.7%) | $152.52 M(+11.4%) |
| Sept 2017 | - | $136.92 M(+1.7%) |
| June 2017 | - | $134.57 M(+1.0%) |
| Mar 2017 | - | $133.19 M(+213.2%) |
| Dec 2016 | $42.52 M(+183.5%) | $42.52 M(-6.7%) |
| Sept 2016 | - | $45.59 M(+46.4%) |
| June 2016 | - | $31.14 M(+1.7%) |
| Mar 2016 | - | $30.63 M(+104.2%) |
| Dec 2015 | $15.00 M(-12.0%) | $15.00 M(+215.5%) |
| Sept 2015 | - | $4.75 M(-45.6%) |
| June 2015 | - | $8.73 M(-31.1%) |
| Mar 2015 | - | $12.68 M(-25.6%) |
| Dec 2014 | $17.05 M(+734.9%) | $17.05 M(+2896.3%) |
| Sept 2014 | - | $569.00 K(+7.6%) |
| June 2014 | - | $529.00 K(-59.5%) |
| Mar 2014 | - | $1.31 M(-36.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $2.04 M(+465.7%) | $2.04 M(-37.1%) |
| Sept 2013 | - | $3.24 M(-61.9%) |
| June 2013 | - | $8.52 M(+1832.0%) |
| Mar 2013 | - | $441.00 K(+22.2%) |
| Dec 2012 | $361.00 K(>+9900.0%) | $361.00 K(+135.9%) |
| Sept 2012 | - | $153.00 K(+37.8%) |
| June 2012 | - | $111.00 K(+94.7%) |
| Mar 2012 | - | $57.00 K(+1800.0%) |
| Dec 2011 | $3000.00(-98.0%) | $3000.00(>+9900.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $34.00 K(-77.6%) |
| Dec 2010 | $152.00 K(-84.6%) | $152.00 K(-50.8%) |
| Sept 2010 | - | $309.00 K(-36.8%) |
| June 2010 | - | $489.00 K(-32.5%) |
| Mar 2010 | - | $724.00 K(-26.5%) |
| Dec 2009 | $985.00 K(-93.3%) | $985.00 K(-26.4%) |
| Sept 2009 | - | $1.34 M(-23.8%) |
| June 2009 | - | $1.76 M(-92.6%) |
| Mar 2009 | - | $23.66 M(+59.8%) |
| Dec 2008 | $14.81 M(-48.9%) | $14.81 M(-18.9%) |
| Sept 2008 | - | $18.27 M(-16.3%) |
| June 2008 | - | $21.83 M(-14.1%) |
| Mar 2008 | - | $25.42 M(-12.4%) |
| Dec 2007 | $29.01 M(-21.2%) | $29.01 M(-12.0%) |
| Sept 2007 | - | $32.97 M(-11.1%) |
| June 2007 | - | $37.09 M(-10.0%) |
| Mar 2007 | - | $41.20 M(+11.9%) |
| Dec 2006 | $36.81 M(+454.7%) | $36.81 M(+453.2%) |
| Sept 2006 | - | $6.65 M(+8.4%) |
| June 2006 | - | $6.14 M(+3.4%) |
| Mar 2006 | - | $5.93 M(-10.6%) |
| Dec 2005 | $6.64 M(-30.2%) | $6.64 M(-4.0%) |
| Sept 2005 | - | $6.91 M(+0.7%) |
| June 2005 | - | $6.87 M(-16.1%) |
| Mar 2005 | - | $8.19 M(-13.8%) |
| Dec 2004 | $9.51 M(-93.5%) | $9.51 M(-2.6%) |
| Sept 2004 | - | $9.76 M(-11.3%) |
| June 2004 | - | $11.01 M(-92.4%) |
| Mar 2004 | - | $144.27 M(-0.8%) |
| Dec 2003 | $145.45 M(+35.4%) | $145.45 M |
| Dec 2002 | $107.38 M(+2946.3%) | - |
| Dec 2001 | $3.52 M(+226.7%) | - |
| Dec 2000 | $1.08 M | - |
FAQ
- What is Cytokinetics Incorporated annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual total long term liabilities year-on-year change?
- What is Cytokinetics Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly long term liabilities year-on-year change?
What is Cytokinetics Incorporated annual total long term liabilities?
The current annual total long term liabilities of CYTK is $1.11 B
What is the all time high annual total long term liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total long term liabilities is $1.11 B
What is Cytokinetics Incorporated annual total long term liabilities year-on-year change?
Over the past year, CYTK annual total long term liabilities has changed by +$69.90 M (+6.73%)
What is Cytokinetics Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of CYTK is $1.34 B
What is the all time high quarterly long term liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total long term liabilities is $1.34 B
What is Cytokinetics Incorporated quarterly long term liabilities year-on-year change?
Over the past year, CYTK quarterly total long term liabilities has changed by +$238.47 M (+21.65%)